Data mining methods for classification of Medium-Chain Acyl-CoA dehydrogenase deficiency (MCADD) using non-derivatized tandem MS neonatal screening data
暂无分享,去创建一个
Seppe K. L. M. vanden Broucke | Tim Van den Bulcke | Viviane Van Hoof | Kristien Wouters | Paul Vanden Broucke | Geert Smits | Elke Smits | Sam Proesmans | Toon Van Genechten | François Eyskens
[1] D. Chace,et al. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. , 2003, Clinical chemistry.
[2] J. Ross Quinlan,et al. C4.5: Programs for Machine Learning , 1992 .
[3] Thomas Wetter,et al. Feature construction can improve diagnostic criteria for high-dimensional metabolic data in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency. , 2007, Clinical chemistry.
[4] Károly Vékey,et al. Direct tandem mass spectrometric analysis of amino acids in dried blood spots without chemical derivatization for neonatal screening. , 2003, Rapid communications in mass spectrometry : RCM.
[5] D. Chace,et al. Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. , 1997, Clinical chemistry.
[6] Trevor Hastie,et al. The Elements of Statistical Learning , 2001 .
[7] A. Fischer,et al. Health in Action Open access, freely available online The European Rare Diseases Therapeutic Initiative A public–private partnership is promoting research on new treatments for rare diseases , 2022 .
[8] S. Cessie,et al. Ridge Estimators in Logistic Regression , 1992 .
[9] Alan Craft,et al. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency , 2001, The Lancet.
[10] Bridget Wilcken,et al. Fatty acid oxidation disorders: outcome and long-term prognosis , 2010, Journal of Inherited Metabolic Disease.
[11] W. Rizzo,et al. Mitochondrial fatty-acid oxidation disorders. , 2008, Seminars in pediatric neurology.
[12] David W. Hosmer,et al. Applied Logistic Regression , 1991 .
[13] Y. T. Chen,et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. , 1993, American journal of human genetics.
[14] Robert Tibshirani,et al. The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd Edition , 2001, Springer Series in Statistics.
[15] M. Morris,et al. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry , 1998, Archives of disease in childhood.
[16] Christian Böhm,et al. Modelling of classification rules on metabolic patterns including machine learning and expert knowledge , 2005, J. Biomed. Informatics.
[17] Ronald J A Wanders,et al. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency. , 2002, Biochimica et biophysica acta.
[18] Christian Böhm,et al. Supervised machine learning techniques for the classification of metabolic disorders in newborns , 2004, Bioinform..
[19] Pedro M. Domingos. MetaCost: a general method for making classifiers cost-sensitive , 1999, KDD '99.